tradingkey.logo

Alpha Teknova Inc

TKNO

4.640USD

+0.240+5.45%
終値 09/18, 16:00ET15分遅れの株価
248.31M時価総額
損失額直近12ヶ月PER

Alpha Teknova Inc

4.640

+0.240+5.45%
詳細情報 Alpha Teknova Inc 企業名
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
企業情報
企業コードTKNO
会社名Alpha Teknova Inc
上場日Jun 25, 2021
最高経営責任者「CEO」Mr. Stephen Gunstream
従業員数173
証券種類Ordinary Share
決算期末Jun 25
本社所在地2451 Bert Drive
都市HOLLISTER
証券取引所NASDAQ Global Market Consolidated
United States of America
郵便番号95023
電話番号18316371100
ウェブサイトhttps://www.teknova.com/
企業コードTKNO
上場日Jun 25, 2021
最高経営責任者「CEO」Mr. Stephen Gunstream
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
Mr. Alexander C. Herzick
Mr. Alexander C. Herzick
Director
Director
--
--
Ms. Brett M. Robertson
Ms. Brett M. Robertson
Independent Director
Independent Director
--
--
Mr. J. Matthew Mackowski
Mr. J. Matthew Mackowski
Director
Director
--
--
Mr. Matthew C. Lowell
Mr. Matthew C. Lowell
Chief Financial Officer
Chief Financial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Lab Essentials
8.12M
82.87%
Clinical Solutions
1.16M
11.86%
Other
516.00K
5.27%
地域別USD
会社名
収益
比率
United States
9.27M
94.66%
International
523.00K
5.34%
事業別
地域別
事業別USD
会社名
収益
比率
Lab Essentials
8.12M
82.87%
Clinical Solutions
1.16M
11.86%
Other
516.00K
5.27%
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
Telegraph Hill Partners
70.48%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
UBS Financial Services, Inc.
2.96%
Balyasny Asset Management LP
1.87%
他の
18.01%
株主統計
株主統計
比率
Telegraph Hill Partners
70.48%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
UBS Financial Services, Inc.
2.96%
Balyasny Asset Management LP
1.87%
他の
18.01%
種類
株主統計
比率
Private Equity
70.48%
Individual Investor
10.72%
Investment Advisor
6.65%
Investment Advisor/Hedge Fund
4.15%
Hedge Fund
2.90%
Research Firm
1.00%
Pension Fund
0.04%
Bank and Trust
0.03%
他の
4.03%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
134
49.86M
93.29%
-910.00K
2025Q1
159
49.02M
94.72%
+9.59M
2024Q4
142
49.19M
92.33%
+11.09M
2024Q3
142
47.90M
89.93%
+8.81M
2024Q2
140
36.69M
87.73%
-3.53M
2024Q1
145
36.60M
90.14%
-2.50M
2023Q4
149
35.47M
91.35%
-3.28M
2023Q3
155
35.09M
90.51%
+4.53M
2023Q2
176
26.14M
92.65%
-5.67M
2023Q1
173
27.23M
97.10%
+13.65M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Telegraph Hill Partners
37.72M
70.58%
--
--
Apr 22, 2025
Davis (Ted)
1.89M
3.53%
--
--
Apr 22, 2025
Davis (Irene)
1.69M
3.16%
--
--
Apr 22, 2025
UBS Financial Services, Inc.
1.16M
2.17%
+46.45K
+4.17%
Mar 31, 2025
Balyasny Asset Management LP
836.96K
1.57%
-164.71K
-16.44%
Mar 31, 2025
Mackowski J Matthew
820.81K
1.54%
--
--
Apr 22, 2025
Lowell (Matthew)
820.81K
1.54%
+701.77K
+589.51%
Apr 22, 2025
The Vanguard Group, Inc.
573.45K
1.07%
+33.21K
+6.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
135.79K
0.25%
-5.84K
-4.12%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI